Grant: Discovery Grants Program - Individual
University of Saskatchewan
$26,000.00
Determining the mechanism of miR-122 regulation of HCV translation
EF 2013-14
Résumé
HCV causes liver disease and cancer, and is a major cause of liver failure, and liver transplantation in North America. Cellular small RNAs, known as microRNAs (miRNA), regulate cellular gene expression. A liver specific miRNA, miR-122, regulates lipid and cholesterol metabolism, and cellular differentiation, and dis-regulation of miR-122 has been linked to liver cancer. Interestingly, miR-122 also modulates the efficiency by which HCV grows in infected cells. Antagonists of miR-122 inhibit HCV infections, and recent phase II trials showed that they are safe and effective in treating HCV infections in humans. However, we currently do not know how miR-122 promotes HCV replication. A direct interaction between miR-122 and the HCV genome is required, but how this promotes virus replication is unknown. In our research we are striving to determine the viral and cellular components that are involved in the activity of miR-122 so that we may learn more about the mechanism of miR-122 activity. We have found that an unconventional form of miR-122 may function to promote HCV, and suggests to us that different populations of miR-122 may exist in cells. We propose to confirm the identity and activity of the unique miR-122 form. We have also identified two host cellular proteins that are involved in miR-122 activity, Ago2 and DDX6. Both Ago2 and DDX6 are required for the mechanism by which normal miRNA regulate host genes, and our goals are to determine their specific roles in promoting HCV replication. With the completion of these studies we will construct a model for the mechanism of miR-122 activation of HCV infections. The information will also provide insight into the role of miR-122 in modulating translation in liver cells.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Saskatchewan, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
342475-2012
Name nom
Wilson, Joyce
Department département
Microbiology and Immunology
Organization id
16
Institution établissement
University of Saskatchewan
Province en
Saskatchewan
Province fr
Saskatchewan
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2012
Award amount
26000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5202
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Virology
Research subject fr
Virologie
Partie
2
Nb partie
5
Application title
Determining the mechanism of miR-122 regulation of HCV translation
Keyword
NSERC
Application summary
HCV causes liver disease and cancer, and is a major cause of liver failure, and liver transplantation in North America. Cellular small RNAs, known as microRNAs (miRNA), regulate cellular gene expression. A liver specific miRNA, miR-122, regulates lipid and cholesterol metabolism, and cellular differentiation, and dis-regulation of miR-122 has been linked to liver cancer. Interestingly, miR-122 also modulates the efficiency by which HCV grows in infected cells. Antagonists of miR-122 inhibit HCV infections, and recent phase II trials showed that they are safe and effective in treating HCV infections in humans. However, we currently do not know how miR-122 promotes HCV replication. A direct interaction between miR-122 and the HCV genome is required, but how this promotes virus replication is unknown. In our research we are striving to determine the viral and cellular components that are involved in the activity of miR-122 so that we may learn more about the mechanism of miR-122 activity. We have found that an unconventional form of miR-122 may function to promote HCV, and suggests to us that different populations of miR-122 may exist in cells. We propose to confirm the identity and activity of the unique miR-122 form. We have also identified two host cellular proteins that are involved in miR-122 activity, Ago2 and DDX6. Both Ago2 and DDX6 are required for the mechanism by which normal miRNA regulate host genes, and our goals are to determine their specific roles in promoting HCV replication. With the completion of these studies we will construct a model for the mechanism of miR-122 activation of HCV infections. The information will also provide insight into the role of miR-122 in modulating translation in liver cells.